Insider Stock Trading History of Bonney Michael W


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bonney Michael W since year 2005. The trader's CIK number is 1219016. At the time of this reporting, Bonney Michael W is the Director of Celgene Corp /de/ . (stock ticker symbol CELG). See this page for all insider trading activities at Celgene Corp /de/ .

Note that in the past BONNEY MICHAEL W also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Bonney Michael W since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-06-15 CELG Celgene Corp /de/ Option Ex 375 .00 0
2016-03-09 ALNY Alnylam Pharmaceuticals, Inc. Buy 2,000 58.36 116,720
2015-08-17 THW Tekla World Healthcare Fund Buy 10,917 18.35 200,294
2015-05-12 ALNY Alnylam Pharmaceuticals, Inc. Buy 2,000 112.16 224,320
2014-07-28 THQ Tekla Healthcare Opportunities Fund Buy 5,000 20.00 100,000
2014-05-14 CBST Cubist Pharmaceuticals Inc Option Ex 6,250 .00 0
2014-05-15 CBST Cubist Pharmaceuticals Inc Sale 3,036 67.50 204,930
2014-05-14 CBST Cubist Pharmaceuticals Inc Sale 3,840 69.00 264,960
2014-05-13 CBST Cubist Pharmaceuticals Inc Option Ex 8,000 .00 0
2014-02-27 CBST Cubist Pharmaceuticals Inc Option Ex 100,000 10.84 1,084,000
2014-02-27 CBST Cubist Pharmaceuticals Inc Sale 100,000 81.25 8,125,100
2014-02-20 CBST Cubist Pharmaceuticals Inc Sale 3,112 75.60 235,267
2014-02-19 CBST Cubist Pharmaceuticals Inc Option Ex 9,500 .00 0
2013-05-20 CBST Cubist Pharmaceuticals Inc Option Ex 60,000 12.61 756,600
2013-05-20 CBST Cubist Pharmaceuticals Inc Sale 60,000 50.00 3,000,000
2013-05-15 CBST Cubist Pharmaceuticals Inc Option Ex 5,000 .00 0
2013-05-16 CBST Cubist Pharmaceuticals Inc Sale 2,400 47.88 114,902
2013-05-15 CBST Cubist Pharmaceuticals Inc Sale 2,979 48.41 144,228
2013-05-14 CBST Cubist Pharmaceuticals Inc Option Ex 6,250 .00 0
2013-02-19 CBST Cubist Pharmaceuticals Inc Option Ex 9,500 .00 0
2013-02-07 NPSP Nps Pharmaceuticals Inc Sale 5,325 8.74 46,540
2013-01-28 CBST Cubist Pharmaceuticals Inc Option Ex 40,352 8.23 332,096
2013-01-29 CBST Cubist Pharmaceuticals Inc Option Ex 65,100 8.23 535,773
2013-01-28 CBST Cubist Pharmaceuticals Inc Sale 40,352 43.09 1,738,929
2013-01-29 CBST Cubist Pharmaceuticals Inc Sale 65,100 42.85 2,789,339
2012-05-14 CBST Cubist Pharmaceuticals Inc Option Ex 6,250 .00 0
2012-05-15 CBST Cubist Pharmaceuticals Inc Option Ex 5,000 .00 0
2012-05-15 CBST Cubist Pharmaceuticals Inc Sale 2,147 41.90 89,961
2012-05-16 CBST Cubist Pharmaceuticals Inc Sale 2,098 41.85 87,801
2012-05-14 CBST Cubist Pharmaceuticals Inc Sale 2,927 41.55 121,625
2012-05-13 CBST Cubist Pharmaceuticals Inc Option Ex 8,000 .00 0
2012-03-09 HQL H&q Life Sciences Investors Buy 800 13.26 10,604
2012-03-09 HQH H&q Healthcare Investors Buy 650 15.80 10,268
2011-12-20 CBST Cubist Pharmaceuticals Inc Sale 19,900 39.15 779,065
2011-12-19 CBST Cubist Pharmaceuticals Inc Sale 130,100 38.61 5,023,681
2011-12-20 CBST Cubist Pharmaceuticals Inc Option Ex 19,900 35.32 702,868
2011-12-19 CBST Cubist Pharmaceuticals Inc Option Ex 130,100 35.32 4,595,132
2011-05-14 CBST Cubist Pharmaceuticals Inc Option Ex 6,250 .00 0
2011-05-15 CBST Cubist Pharmaceuticals Inc Option Ex 5,000 .00 0
2010-05-15 CBST Cubist Pharmaceuticals Inc Option Ex 5,000 .00 0
2010-04-22 CBST Cubist Pharmaceuticals Inc Sale 21,000 22.22 466,662
2010-04-21 CBST Cubist Pharmaceuticals Inc Sale 163,548 22.56 3,689,642
2010-04-22 CBST Cubist Pharmaceuticals Inc Option Ex 91,000 14.92 1,357,720
2010-04-21 CBST Cubist Pharmaceuticals Inc Option Ex 163,548 7.91 1,292,846
2005-05-17 NPSP Nps Pharmaceuticals Inc Buy 4,000 12.95 51,800

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bonney Michael W (Director of Celgene Corp /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.